Please use this identifier to cite or link to this item:
|Title:||Outcomes of patients with post-hepatectomy hypophosphatemia: a narrative review||Authors:||Chan, Kai Siang
Shelat, Vishal G.
|Keywords:||Science::Medicine||Issue Date:||2022||Source:||Chan, K. S., Mohan, S. & Shelat, V. G. (2022). Outcomes of patients with post-hepatectomy hypophosphatemia: a narrative review. World Journal of Hepatology, 14(8), 1550-1561. https://dx.doi.org/10.4254/wjh.v14.i8.1550||Journal:||World Journal of Hepatology||Abstract:||Phosphate is an essential electrolyte for proper mineralisation of bone, buffering of urine, and diverse cellular actions. Hypophosphatemia (HP) is a clinical spectrum which range from asymptomatic to severe complications such as neuromuscular and pulmonary complications, or even death. Post-hepatectomy HP (PHH) has been reported to be 55.5%-100%. Post-hepatectomy, there is rapid uptake of phosphate and increased mitotic counts to aid in regeneration of residual liver. Concurrently, PHH may be due to increased urinary phosphorous from activation of matrix extracellular phosphoglycoprotein in the injured liver, which decreases phosphate influx into hepatocytes to sustain adenosine triphosphate synthesis. A literature review was performed on PubMed till January 2022. We included 8 studies which reported on impact of PHH on post-operative outcomes. In patients with diseased liver, PHH was reported to have either beneficial or deleterious effects on post-hepatectomy liver failure (PHLF), morbidity and/or mortality in various cohorts. In living donor hepatectomy, PHLF was higher in PHH. Benefits of correction of PHH with reduced post-operative complications have been shown. Correction of PHH should be done based on extent of PHH. Existing studies were however heterogenous; further studies should be conducted to assess PHH on post-operative outcomes with standardized phosphate replacement regimes.||URI:||https://hdl.handle.net/10356/163140||ISSN:||1948-5182||DOI:||10.4254/wjh.v14.i8.1550||Rights:||©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Updated on Jan 27, 2023
Updated on Jan 27, 2023
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.